Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF397 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | SREBF2 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | RARS | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | C21orf2 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | HDAC2 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | RAB13 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-05 |
mRNA | PPFIA2 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | ANLN | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
mRNA | LMAN1 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | REPIN1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |